J Korean Diabetes > Volume 14(3); 2013 > Article
The Journal of Korean Diabetes 2013;14(3):138-142.
DOI: https://doi.org/10.4093/jkd.2013.14.3.138    Published online September 30, 2013.
DPP-4 억제제의 췌장 외 영향 (심혈관 질환, 암, 췌장염 등)
Effect of DPP-4 Inhibitors on the Cardiovascular System, Cancer and Pancreatitis.
Eun Hee Cho
Department of Internal Medicine, School of Medicine, Kangwon National University, Chuncheon, Korea. ehcho@kangwon.ac.kr
Recently, dipeptidylpeptidase-4 (DPP-4) inhibitors have been widely used as a second-line therapy for type 2 diabetes because of their glucose-lowering efficacy, weight neutral effects and minimal hypoglycemia. However, there have been concerns regarding the lack of evidence of the long-term consequences of DPP-4 inhibitors on cardiovascular disease, acute pancreatitis and cancers; therefore, the effects of DPP-4 inhibitors on these three major diseases are reviewed in this article. A growing body of evidence demonstrates the cardioprotective role of DPP-4 inhibitors in animal and small clinical studies. However, clearly conflicting data regarding the effects of DPP-4 inhibitors on cancers and pancreatitis have been presented in preclinical and epidemiologic studies. The forthcoming long-term clinical studies on cardiovascular safety will provide more conclusive answers relating to the safety of DPP-4 inhibitors, including their effects on cancer and pancreatitis.
Key Words: Dipeptidyl-peptidase IV inhibitors, Cardiovascular diseases, Neoplasms, Pancreatitis

Editorial Office
101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea​
Tel: +82-2-714-9064    Fax: +82-2-714-9084    E-mail: diabetes@kams.or.kr                

Copyright © 2024 by Korean Diabetes Association. All rights reserved.

Developed in M2PI

Close layer